Usui M - Search Results

1

Technical Feasibility and Clinical Outcomes of Interventional Endovascular Treatment for Hepatic Artery Thrombosis After Living-donor Liver Transplantation.

Murata Y, Mizuno S, Kato H, Tanemura A, Kuriyama N, Azumi Y, Kishiwada M, Usui M, Sakurai H, Fujimori M, Yamanaka T, Nakatsuka A, Yamakado K, Isaji S. Murata Y, et al. Among authors: usui m. Transplant Proc. 2016 May;48(4):1142-8. doi: 10.1016/j.transproceed.2015.12.092. Transplant Proc. 2016. PMID: 27320575

2

Postoperative liver dysfunction in living donors after left-sided graft hepatectomy: portal venous occlusion of the medial segment after lateral segmentectomy and hepatic venous congestion after left lobe hepatectomy.

Kumamoto K, Mizuno S, Kuriyama N, Ohsawa I, Kishiwada M, Hamada T, Usui M, Sakurai H, Tabata M, Isaji S. Kumamoto K, et al. Among authors: usui m. Transplant Proc. 2012 Mar;44(2):332-7. doi: 10.1016/j.transproceed.2012.01.023. Transplant Proc. 2012. PMID: 22410009

3

Living donor liver transplantation for the patients with portal vein thrombosis: use of an interpositional venous graft passed posteriorly to the pancreatic parenchyma without using jump graft.

Mizuno S, Murata Y, Kuriyama N, Ohsawa I, Kishiwada M, Hamada T, Usui M, Sakurai H, Tabata M, Isaji S. Mizuno S, et al. Among authors: usui m. Transplant Proc. 2012 Mar;44(2):356-9. doi: 10.1016/j.transproceed.2012.01.039. Transplant Proc. 2012. PMID: 22410015

4

Negative prognostic impact of renal replacement therapy in adult living-donor liver transplant recipients: preoperative recipient condition and donor factors.

Iwata H, Mizuno S, Ishikawa E, Tanemura A, Murata Y, Kuriyama N, Azumi Y, Kishiwada M, Usui M, Sakurai H, Tabata M, Yamamoto N, Sugimoto K, Shiraki K, Takei Y, Ito M, Isaji S. Iwata H, et al. Among authors: usui m. Transplant Proc. 2014 Apr;46(3):716-20. doi: 10.1016/j.transproceed.2013.11.113. Transplant Proc. 2014. PMID: 24767332

5

Hypertension and hepatitis C virus infection are strong risk factors for developing late renal dysfunction after living donor liver transplantation: significance of renal biopsy.

Fujinaga K, Usui M, Yamamoto N, Ishikawa E, Nakatani A, Kishiwada M, Mizuno S, Sakurai H, Tabata M, Isaji S. Fujinaga K, et al. Among authors: usui m. Transplant Proc. 2014 Apr;46(3):804-10. doi: 10.1016/j.transproceed.2013.11.103. Transplant Proc. 2014. PMID: 24767353

6

Biliary complications in 108 consecutive recipients with duct-to-duct biliary reconstruction in living-donor liver transplantation.

Mizuno S, Inoue H, Tanemura A, Murata Y, Kuriyama N, Azumi Y, Kishiwada M, Usui M, Sakurai H, Tabata M, Yamada R, Yamamoto N, Sugimoto K, Shiraki K, Takei Y, Isaji S. Mizuno S, et al. Among authors: usui m. Transplant Proc. 2014 Apr;46(3):850-5. doi: 10.1016/j.transproceed.2013.11.035. Transplant Proc. 2014. PMID: 24767364

7

Thrombomodulin administration attenuates ischemia-reperfusion injury of the remnant liver after 70% hepatectomy in rats: simulated model of small-for-size graft in living donor liver transplantation.

Tanemura A, Kuriyama N, Azumi Y, Ohsawa I, Kishiwada M, Mizuno S, Usui M, Sakurai H, Tabata M, Isaji S. Tanemura A, et al. Among authors: usui m. Transplant Proc. 2014 May;46(4):1107-11. doi: 10.1016/j.transproceed.2013.11.128. Transplant Proc. 2014. PMID: 24815140

8

D-MELD, the Product of Donor Age and Preoperative MELD, Predicts Surgical Outcomes After Living Donor Liver Transplantation, Especially in the Recipients With HCV-positive and Smaller Grafts.

Tanemura A, Mizuno S, Kato H, Murata Y, Kuriyama N, Azumi Y, Kishiwada M, Usui M, Sakurai H, Isaji S. Tanemura A, et al. Among authors: usui m. Transplant Proc. 2016 May;48(4):1025-31. doi: 10.1016/j.transproceed.2015.12.090. Transplant Proc. 2016. PMID: 27320548

9

Long-Term Influence of CYP3A5 Gene Polymorphism on Pharmacokinetics of Tacrolimus and Patient Outcome After Living Donor Liver Transplantation.

Kato H, Usui M, Muraki Y, Tanemura A, Murata Y, Kuriyama N, Azumi Y, Kishiwada M, Mizuno S, Sakurai H, Okuda M, Nakatani K, Isaji S. Kato H, et al. Among authors: usui m. Transplant Proc. 2016 May;48(4):1087-94. doi: 10.1016/j.transproceed.2016.02.012. Transplant Proc. 2016. PMID: 27320564

10

Discontinuation of Hepatitis B Immunoglobulin by Long-term Hepatitis B Vaccine Inoculation in Preventing Hepatitis B Recurrence After Liver Transplantation.

Usui M, Sugimoto K, Kato H, Murata Y, Tanemura A, Kuriyama N, Azumi Y, Kishiwada M, Mizuno S, Sakurai H, Takei Y, Isaji S. Usui M, et al. Transplant Proc. 2016 May;48(4):1179-83. doi: 10.1016/j.transproceed.2015.12.110. Transplant Proc. 2016. PMID: 27320582

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,034 results

Search Page

Filters